Posted on 8/11/20
Humana Expands Relationship With Seniorlink
Seniorlink, Inc., a leading tech-enabled health services company, is pleased to announce an expanded relationship with leading health and well-being company Humana Inc. (NYSE: HUM) focused . . .
Posted on 8/11/20
Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company Update
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today reported financial results . . .
Posted on 8/11/20
Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, . . .
Posted on 8/11/20
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically . . .
Posted on 8/11/20
Navin, Haffty & Associates and Engage Join Forces to Provide Clients Complete MEDITECH Solutions
Navin, Haffty & Associates is joining forces with Engage IT Services, Inc. to create the industry's most comprehensive and complete MEDITECH professional services offering. This union . . .
Posted on 8/11/20
States with the Fewest Coronavirus Restrictions – WalletHub Study
With many states delaying the later phases of their reopening or even bringing back restrictions they already lifted due to spikes in COVID-19, the personal-finance website . . .
Posted on 8/11/20
Why Moderna Is Moving Nowhere For Now
SummaryModerna fell sharply after briefly trading close to $100.Quarterly earnings update failed to inspire investors.Investors ignoring improving fundamentals.I do much more than just articles at DIY . . .
Posted on 8/11/20
Biogen: An Undervalued Opportunity In An Overpriced Market
SummaryBiogen has an impressive portfolio of assets that it is continuing to work towards developing. The most exciting of these is Aducanumab.Even if Aducanumab isn't approved, . . .
Posted on 8/11/20
Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business Update
BEDFORD, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the second quarter ended . . .
Posted on 8/11/20
Mustang Bio Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
WORCESTER, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and . . .
Posted on 8/10/20
AVEO Oncology Provides Business Update
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today reported financial results for the second quarter ended June 30, 2020 and provided a business update.“The first half of 2020 . . .
Posted on 8/10/20
AVEO Oncology Announces Restructuring of Existing Term Loan with Closing of New Tranched, $35M Debt Facility
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the closing of a tranched, $35 million debt facility with Hercules Capital, Inc. (NYSE: HTGC) and its affiliates. The . . .
Posted on 8/10/20
Stoke Therapeutics Provides Business Updates
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein . . .
Posted on 8/10/20
Sesen Bio Reports Second Quarter 2020 Financial Results and Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results . . .
Posted on 8/10/20
Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3M
BOSTON, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies . . .
Posted on 8/10/20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating . . .
Posted on 8/10/20
Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results
CAMBRIDGE, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat . . .
Posted on 8/10/20
Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
CAMBRIDGE, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR) today reported its second quarter 2020 financial results, program progress and corporate updates.“We . . .
Posted on 8/10/20
LogicBio Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates
LEXINGTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a company dedicated to extending the reach of genetic medicine with pioneering targeted delivery . . .
Posted on 8/10/20
Why Vertex Pharmaceuticals Is the Best Biotech Stock to Buy in August
Cystic fibrosis (CF)is a life-threatening genetic disorder that causes mucus to accumulate in the lungs, digestive system, and other organs in the body, resulting in severe . . .
Posted on 8/9/20
Allena Pharmaceuticals Provides Business Update
NEWTON, Mass., (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare . . .
Posted on 8/9/20
AlloVir Closes Upsized IPO
CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced the closing of its upsized initial . . .
Posted on 8/7/20
Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Royalty Pharma (Nasdaq: RPRX) announced today that Biohaven has secured up to $250 million in funding to advance . . .
Posted on 8/7/20
Biohaven Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced that it entered into a $500 million non-dilutive term loan financing facility with Sixth Street, a leading global . . .
Posted on 8/7/20
Syndax Pharmaceuticals Provides Clinical and Business Update
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the second quarter . . .
Boston
